Trial Search Results

Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble Swallowing

FLIP topography has been FDA cleared to evaluate a variety of esophageal conditions, but has never been evaluated in patients with scleroderma. The investigators hope to evaluate this technology in patients who have scleroderma and various esophageal symptoms, and compare to non-scleroderma patients.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University


  • Device: FLIP topography
  • Procedure: Upper Endoscopy




Inclusion Criteria:

   - Must have a clinical indication for upper endoscopy (recruiting patients both with
   scleroderma and without)

Exclusion Criteria:

   - not healthy enough to undergo an upper endoscopy

   - mass, stricture, ring, or web present on upper endoscopy

   - history of esophageal cancer

   - history of esophageal surgery

Ages Eligible for Study

18 Years - 90 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
John O Clarke, MD
Not Recruiting